Adcendo Aps
Clinical trials sponsored by Adcendo Aps, explained in plain language.
-
New drug ADCE-B05 targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called ADCE-B05 in people with advanced solid tumors that have not responded to standard treatments. The main goals are to find the safest dose and check for side effects. About 180 participants will receive the drug to see how well it is t…
Phase: PHASE1 • Sponsor: Adcendo ApS • Aim: Disease control
Last updated May 26, 2026 05:59 UTC
-
New drug targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study tests an investigational drug called ADCE-T02 in people with advanced solid tumors that have not responded to prior treatments. The drug is designed to seek out and attack cancer cells by targeting a protein called tissue factor. The main goals are to find …
Phase: PHASE1 • Sponsor: Adcendo ApS • Aim: Disease control
Last updated May 26, 2026 05:47 UTC
-
New drug targets Hard-to-Treat sarcomas in early trial
Disease control Recruiting nowThis study tests a new drug called ADCE-D01 for people with soft tissue sarcoma that has spread or cannot be removed by surgery. The drug is designed to find and attack cancer cells while leaving healthy cells alone. About 270 adults will take part to see if the drug is safe and …
Phase: PHASE1, PHASE2 • Sponsor: Adcendo ApS • Aim: Disease control
Last updated May 22, 2026 13:55 UTC